Formulation and Design of Metformin Hydrochloride Extended Release Tablets
Abstract
Aim: The current paper was an attempt to design a extended release dosage form of Metformin hydrochloride using various grades of hydrophilic polymers, hydroxy propyl methyl cellulose (HPMC K4M, HPMC K15M, HPMC K100M and HPMC K200M) and MCC.
Materials and Methods: Laboratory scale batches of 4 tablet formulations were prepared by wet granulation technique. Precompression parameters of the granules were evaluated prior to compression. Tablets were characterized as crushing strength, friability, weight variation, thickness, drug content or assay and evaluated for in-vitro release pattern for 12 hr using Phosphate buffer of pH 6.8 at 37 ± 0.5°C.
Results and Discussion: The results obtained revealed that HPMC K100M in formulation (F3) was able to sustain the drug release for 12 h and followed the Higuchi pattern quasi-Fickian diffusion. and charged for stability testing, parameters were within the limit of acceptance. There was no chemical interaction found between the drug and excipients during Fourier Transform Infrared Spectroscopy (FTIR).
Conclusion: Hence it can be concluded that formulation F3 containing HPMC K100M is suitable for development of extended release tablets of Metformin Hydrochloride.
References
2. Ashok kumar.A, Balakrishna.t, Rajiv jash, T.E.G.K Murthy, Anil kumar.A, B. Sudheer:. Int j pharm pharm sci; 3(suppl 3) 150-155. 2011.
3. Dunn CJ, Peters DH: Metformin: Drugs; 49: 721-749. 1995
4. T. Satyanarayana, V. Rajitha, P. Suresh Kumar, K. Ravinder, G. Shaji and P. Saranya: Formulation and evaluation of Metformin HCl extended release tablets, Pelagia Research Library, Der Pharmacia Sinica, 2012, 3 (1):58-63
5. Pogula M, Nazeer S, International Journal of Pharmacy and Technology, 2010, 02(04), 625-84
6. Jayanthi B, Manna P K, Madhusudhan S, Mohanta G P, Manavalan R, Journal of Applied Pharmaceutical Science, 2011, 01(02), 50-55
7. Khan G M, The Sciences, 2001, 01(05), 350-54
8. M. Rajesh, mohan kumar pippalla, krsc. Bharath kumar, m. Shunmuga sundaram, s. Palanichamy and a. Thanga thirupathi: formulation and evaluation of extended release tablets of metformin hydrochloride, international journal of pharmaceutical, chemical and biological sciences (ijpcbs) 2012, 2(3), 318-324.
9. Vamsy krishna.a, K.R.Srinath ,C.Pooja Chowdary Palanisamy.p, G.R.Vijayasankar: Formulation Development and Evaluation of Divalproex Sodium Extended Release Tablets, International Journal of Research in Pharmaceutical and Biomedical Sciences 2011, Vol. 2 (2).
10. Herbert A, Liberman, Leon Lachman, Joseph B. Schwartz. Pharmaceutical Dosage Forms, Tablets. New York Marcel Dekker Inc, 1989; 2nd Ed. Vol-I: 195-197, 285-286.
11. Muhammad Akhlaq, Gul Majid Khan, Abdul Wahab, Abid Hussain, Arshad Khan, Asif Nawaz And Kifayat Ullah Shah: Formulation And In-Vitro Evaluation Of Flurbiprofen Controlled Release Matrix Tablets Using Cellulose Derivative Polymers, Pak. J. Pharm2007-2010. 20-23 (1 & 2) 23-29.
12. Sharma, Shukla, Indoria Manish and Jha sajal: Design, Development and Evaluation of Aceclofenac Sustained release matrix tablets, International Journal of Drug Development & Research.2011;3(1):303-313.
13. Sandeep Divate, Kunchu Kavitha, Ganesh Nanjan Sockan: Fast Disintegrating Tablets – An Emerging Trend, International Journal of Pharmaceutical Sciences Review and Research. 2011;6(2):18-22.
14. British Pharmacopoeia. British Pharmacopoeial Commission, London, 2000; Vol-2: 209,299.
15. Kuldeep Malodia, Anil Kumar, Sunil Kumar and Pankaj Rakha: Formulation and evaluation of extended release tablets of salbutamol sulphate, Scholars Research Library Der Pharmacia Lettre, 2013, 5 (1):177-181
16. The United State of Pharmacopoeia 24/NF26. The official compendia of United States of pharmacopoeial Convection Inc. Rockville, 1995; Asian Ed.:1015-1016.
17. Cooper J, Gunn C, Tutorial pharmacy, New Delhi, CBS Publishers and Distributors, 1986, 06, 211-33
18. Stability Testing of Active Substances and Pharmaceutical Products. World Health organization.1211 Geneva, Switzerland, 2006: 1-33.
19. Prescribing Information for Stability studies Available from: fda.com.
20. Prescribing Information for Stability studies Available from: microtestlabs.com/ asepticprocessing/stability/index-html
